Microtubular disruption prolongs the expression of human bilirubin-uridinediphosphoglucuronate-glucuronosyltransferase-1 gene transferred into Gunn rat livers. 1996

N R Chowdhury, and R M Hays, and V R Bommineni, and N Franki, and J R Chowdhury, and C H Wu, and G Y Wu
Marion Bessin Liver Research Center, Albert Einstein College of Medicine, Bronx, New York 10461, USA.

DNA delivered to the liver by asialoglycoprotein receptor-mediated endocytosis is degraded in lysosomes within 48 h. To test the hypothesis that microtubular disruption should promote transgene persistence by interrupting endosomal translocation to lysosomes, plasmids containing bacterial chloramphenicol acetyltransferase (pSV2-CAT) or human bilirubin-UDP-glucuronosyltransferase-1 (pSVK3-hBUGT1) genes were complexed with asialoglycoprotein-polylysine conjugates, and 1 mg of the complexed DNA was injected intravenously into bilirubin-UDP-glucuronosyltransferase-deficient Gunn rats. 30 min before DNA injection, one group received 0.75 mg of colchicine/kg of body weight intraperitoneally, which was shown by immunofluorescent confocal microscopy to disrupt the microtubular network. Control rats received normal saline. In colchicine-pretreated rats receiving pSV2-CAT, hepatic chloramphenicol acetyltransferase activity persisted for 9-14 weeks, whereas in the saline-pretreated group the activity was detectable for 48 h only. In colchicine-pretreated Gunn rats receiving pSVK3-hBUGT1, the DNA persisted in liver for 10 weeks, bilirubin glucuronides were excreted in bile, and serum bilirubin levels declined by 25-35% in 2-4 weeks and remained reduced for 8 weeks. Without colchicine pretreatment, the DNA was detectable in liver for 2 days only, and serum bilirubin levels were not reduced. Thus, microtubular disruption provides a noninvasive method for prolonging the effect of liver-targeted gene therapy.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008247 Lysosomes A class of morphologically heterogeneous cytoplasmic particles in animal and plant tissues characterized by their content of hydrolytic enzymes and the structure-linked latency of these enzymes. The intracellular functions of lysosomes depend on their lytic potential. The single unit membrane of the lysosome acts as a barrier between the enzymes enclosed in the lysosome and the external substrate. The activity of the enzymes contained in lysosomes is limited or nil unless the vesicle in which they are enclosed is ruptured or undergoes MEMBRANE FUSION. (From Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed). Autolysosome,Autolysosomes,Lysosome
D008297 Male Males
D008870 Microtubules Slender, cylindrical filaments found in the cytoskeleton of plant and animal cells. They are composed of the protein TUBULIN and are influenced by TUBULIN MODULATORS. Microtubule
D011911 Rats, Gunn Mutant strain of Rattus norvegicus which is used as a disease model of kernicterus. Gunn Rat,Gunn Rats,Rat, Gunn
D003078 Colchicine A major alkaloid from Colchicum autumnale L. and found also in other Colchicum species. Its primary therapeutic use is in the treatment of gout, but it has been used also in the therapy of familial Mediterranean fever (PERIODIC DISEASE). Colchicine, (+-)-Isomer,Colchicine, (R)-Isomer
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004705 Endocytosis Cellular uptake of extracellular materials within membrane-limited vacuoles or microvesicles. ENDOSOMES play a central role in endocytosis. Endocytoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

N R Chowdhury, and R M Hays, and V R Bommineni, and N Franki, and J R Chowdhury, and C H Wu, and G Y Wu
March 1996, The Biochemical journal,
N R Chowdhury, and R M Hays, and V R Bommineni, and N Franki, and J R Chowdhury, and C H Wu, and G Y Wu
March 1998, Human gene therapy,
N R Chowdhury, and R M Hays, and V R Bommineni, and N Franki, and J R Chowdhury, and C H Wu, and G Y Wu
June 1991, Biochemical and biophysical research communications,
N R Chowdhury, and R M Hays, and V R Bommineni, and N Franki, and J R Chowdhury, and C H Wu, and G Y Wu
May 1966, The Journal of laboratory and clinical medicine,
N R Chowdhury, and R M Hays, and V R Bommineni, and N Franki, and J R Chowdhury, and C H Wu, and G Y Wu
April 1984, Clinical science (London, England : 1979),
N R Chowdhury, and R M Hays, and V R Bommineni, and N Franki, and J R Chowdhury, and C H Wu, and G Y Wu
December 2001, Digestive diseases and sciences,
N R Chowdhury, and R M Hays, and V R Bommineni, and N Franki, and J R Chowdhury, and C H Wu, and G Y Wu
January 1996, Advances in enzyme regulation,
N R Chowdhury, and R M Hays, and V R Bommineni, and N Franki, and J R Chowdhury, and C H Wu, and G Y Wu
March 1995, Hepatology (Baltimore, Md.),
N R Chowdhury, and R M Hays, and V R Bommineni, and N Franki, and J R Chowdhury, and C H Wu, and G Y Wu
March 1992, FEBS letters,
N R Chowdhury, and R M Hays, and V R Bommineni, and N Franki, and J R Chowdhury, and C H Wu, and G Y Wu
May 1995, Artificial organs,
Copied contents to your clipboard!